U.S. flag An official website of the United States government
  1. Home
  2. Vaccines, Blood & Biologics
  3. Development & Approval Process (CBER)
  4. 2022 Biological License Application Approvals
  1. Development & Approval Process (CBER)

2022 Biological License Application Approvals

This list reflects information regarding the applications as of the approval date. It is not updated with regard to applicant or application status changes. The applications are listed by date of approval in reverse chronological order.

2022 Biological License Application Approvals
Tradename/Proper Name Indication for Use STN Manufacturer/
License Number
Approval Date
Alinity s Anti-HCV II Reagent Kit
Hepatitis C Virus (E coli, Recombinant) NS3 Helicase Antigens and Synthetic Core Peptide
Intended to screen individual human donors, including volunteer donors of whole blood and blood components, and other living donors for the presence of anti- HCV. The assay is also intended for use in testing serum and plasma specimens to screen organ donors when specimens are obtained while the donor's heart is still beating, and in testing serum and EDTA plasma specimens to screen cadaveric (nonheart- beating) donors. It is not intended for use on cord blood specimens. 125759/0 Abbott GmbH
Abbott Laboratories
Dept T3M2, Bldg. AP20
100 Abbott Park Road
Abbott Park, IL 60064

Lic. # 2095
07/15/2022
PRIORIX
Measles, Mumps and Rubella Vaccine Live
Indicated for active immunization for the prevention of measles, mumps, and rubella in individuals 12 months of age and older. 125748/0 GlaxoSmithKline Biologicals SA
1250 South Collegeville Road
Collegeville,
PA 19426

Lic. # 1617
06/03/2022
DG Gel 8 Direct Coombs (Anti-IgG, -C3d)
Anti-Human Globulin (Rabbit/Murine Monoclonal)
Indicated for use with the DG Gel System to detect in vivo coating of human red blood cells with IgG and C3d (direct antiglobulin test). 125705/0 Diagnostic Grifols, S.A.
Avda. de la Gerneralitat, 152
Sant Cugat del Valles
Barcelona 08174
Spain

Lic. # 1887
05/20/2022
Anti-Human Globulin Anti-C3d FFMU, Murine Monoclonal
Anti-Human Globulin (Murine Monoclonal) (For Further Manufacturing Use)
Indicated for further manufacturing use in the production of Anti-IgG, -C3d Anti-Human Globulin under a Shared Manufacturing Agreement with Diagnostic Grifols, S.A. 125707/0 Diagast
NAMSA
400 Highway 169 South, Suite 500
Minneapolis, MN 55426

Lic. # 1744
05/20/2022
Anti-Human Globulin Anti-C3d FFMU, Murine Monoclonal
Anti-Human Globulin (Murine Monoclonal) (For Further Manufacturing Use)
Indicated for further manufacturing use in the production of Anti-IgG, -C3d Anti-Human Globulin under a Shared Manufacturing Agreement with Diagnostic Grifols, S.A. 125708/0 Diagast
NAMSA
400 Highway 169 South, Suite 500
Minneapolis, MN 55426

Lic. # 1744
05/20/2022
DG Gel 8 Direct Coombs (Anti-C3d)
Anti-Human Globulin (Murine Monoclonal)
Indicated for use with the DG Gel System to detect in vivo coating of human red blood cells with C3d (direct antiglobulin test). 125711/0 Diagnostic Grifols, S.A.
Avda. de la Gerneralitat, 152
Sant Cugat del Valles
Barcelona 08174
Spain

Lic. # 1887
05/20/2022
CARVYKTI
ciltacabtagene autoleucel
Is indicated for the treatment of adult patients with relapsed or refractory multiple myeloma after four or more prior lines of therapy, including a proteasome inhibitor, an immunomodulatory agent, and an anti-CD38 monoclonal antibody. 125746/0 Janssen Biotech, Inc.
920 US Highway 202
P.O. Box 300
Raritan, NJ 08869

Lic. # 1864
02/28/2022
SPIKEVAX
COVID-19 Vaccine, mRNA
Active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 18 years of age and older 125752/0 ModernaTX, Inc.
200 Technology Square
Cambridge, MA 02139

Lic. # 2256
01/31/2022

 

Back to Top